|
It was reported on (b)(6) 2026 that the patient presented with grade 4 functional mitral regurgitation (mr) and restricted posterior leaflet for a mitraclip procedure.During the procedure, a mitraclip was successfully implanted.The mr was reduced to grade <1 post procedure.Approximately after 2 months of deployment, the mitraclip xtw had single leaflet device attachment (slda) from the posterior leaflet.Recurrent mr of grade 3 was reported along with dyspnea.On (b)(6) 2026, a re-interventional procedure was performed.Additional 2 mitraclips were implanted to stabilize the slda clip.The mr was reduced to grade 1-2 post procedure.There was no clinically significant delay reported.
|
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Additionally, a review of the complaint history identified no similar complaints from the lot.Based on the available information, the cause of the reported incomplete coaptation could not be determined.The reported dyspnea and recurrent mr appear to be cascading effects of the reported slda.Mr and shortness of breath, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The reported hospitalization and unexpected medical intervention were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|